Bolton Sheryle
Director
PurchaseAlert
- Shares
- 10,000
- Price
- $1.04
- Value
- $10,400
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•24 filings
VBIO
Valion Bio, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$28,408
2 distinct insiders
12-month sales
$0.00
0 distinct insiders
Highlighted alerts
2
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get VBIO insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
VBIO overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
28
Raw transactions
Everything returned by the filing
2
Voluntary view
P/S trades after deterministic checks
26
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 50,000
- Price
- $0.00
- Footnotes
- 3
Each Restricted Stock Unit is convertible into one share of Common Stock. One fourth (1/4) of the Restricted Stock Units shall vest quarterly, with the first vesting occurring on December 22, 2026. These numbers have been adjusted to reflect the reverse stock split of the common stock of Valion Bio, Inc., which underwent a reverse stock split at a ratio of 1-for-25 on August 31, 2026.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Valauri Christina Rizopoulos
Director
PurchaseAlert
- Shares
- 19,000
- Price
- $0.95
- Value
- $18,008
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.